Sale!

ACTG1 Gene Deafness Autosomal Dominant Type 20 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ACTG1 gene, associated with Autosomal Dominant Deafness Type 20 (DFNA20), plays a crucial role in the function and structure of inner ear cells, which are essential for hearing. Mutations in the ACTG1 gene can lead to hearing impairment, typically characterized by progressive, sensorineural hearing loss. This condition is inherited in an autosomal dominant pattern, meaning that a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.

To diagnose this specific type of genetic hearing loss, a genetic test targeting the ACTG1 gene can be conducted. DNA Labs UAE offers such a test, providing a comprehensive analysis to detect mutations in the ACTG1 gene that are responsible for Autosomal Dominant Deafness Type 20. The test is crucial for individuals with a family history of hearing loss or those experiencing symptoms of hearing impairment, as it can confirm the diagnosis, guide management and treatment decisions, and inform family planning.

The cost of the ACTG1 Gene Deafness Autosomal Dominant Type 20 Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted in a state-of-the-art laboratory setting by experienced geneticists and technicians, ensuring accurate and reliable results. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for the presence of mutations in the ACTG1 gene.

By opting for this genetic test, individuals and families can gain valuable insights into the genetic basis of hearing loss, enabling informed decisions regarding healthcare and lifestyle adjustments to better manage the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ACTG1 Gene Deafness Autosomal Dominant Type 20 Genetic Test

At DNA Labs UAE, we offer the ACTG1 Gene Deafness Autosomal Dominant Type 20 Genetic Test. This test helps diagnose individuals with autosomal dominant type 20 deafness, which is associated with the ACTG1 gene.

Test Components

  • Price: 4400.0 AED

Sample Condition

We require a blood sample for this test.

Report Delivery

The test results will be delivered within 3 to 4 weeks.

Method

We use NGS (Next-Generation Sequencing) technology for this genetic test.

Test Type

This test is specifically designed for Ear Nose Throat Disorders.

Doctor

This test is conducted by an ENT Doctor.

Test Department

This test falls under the Genetics department.

Pre Test Information

Before undergoing the EYA1 Gene Branchiootic Syndrome Type 1 NGS Genetic DNA Test, we recommend a Genetic Counselling session to gather the clinical history of the patient. This session will also help draw a pedigree chart of family members affected by the EYA1 Gene Branchiootic Syndrome Type 1 NGS Genetic DNA Test gene EYA3.

Test Details

The ACTG1 gene is associated with a type of deafness known as autosomal dominant type 20. This means that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition. Our NGS genetic test can analyze multiple genes simultaneously, including the ACTG1 gene, to identify any mutations or variations that may be causing the condition.

To perform this test, we will obtain a DNA sample, usually through a blood sample or cheek swab, and then sequence the DNA to identify any genetic changes in the ACTG1 gene. This information can help diagnose individuals with autosomal dominant type 20 deafness and provide insights into the specific genetic variant causing the condition.

NGS genetic testing is particularly beneficial for individuals and families with a history of deafness or suspected genetic conditions. It can aid in accurate diagnosis, provide information about the inheritance pattern, and assist in genetic counseling and family planning decisions.

Test Name ACTG1 Gene Deafness autosomal dominant type 20 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with EYA1 Gene Branchiootic syndrome type 1 NGS Genetic DNA Test gene EYA3
Test Details

The ACTG1 gene is associated with a type of deafness known as autosomal dominant type 20. Autosomal dominant means that a person only needs to inherit one copy of the mutated gene from one parent to develop the condition.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. In the case of ACTG1 gene deafness, an NGS genetic test can identify any mutations or variations in the ACTG1 gene that may be causing the condition.

The test involves obtaining a DNA sample, usually through a blood sample or cheek swab, and then sequencing the DNA to identify any genetic changes in the ACTG1 gene. This can help diagnose individuals with autosomal dominant type 20 deafness and provide information about the specific genetic variant causing the condition.

NGS genetic testing can be beneficial for individuals and families with a history of deafness or suspected genetic conditions. It can help with accurate diagnosis, provide information about the inheritance pattern, and assist in genetic counseling and family planning decisions.